CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Noncontrolling Interest	Total
Stockholders Equity, Beginning balance at Mar. 31, 2018	$ 16,862	$ 70,961,104	$ (58,229,235)	$ 2,882,990	$ 15,631,721
Shares, Outstanding Beginning balance at Mar. 31, 2018	168,616,855
Issuance of stock for debt conversion, value	$ 1,856	4,639,115			4,640,971
Issuance of stock for debt conversion, shares	18,563,885
Exercise of warrants for stock, value	$ 1,266	3,919,454			3,920,720
Exercise of warrants for stock, shares	12,657,875
Issuance of stock for services, value	$ 154	741,535			741,689
Issuance of stock for services, shares	1,543,844
Share based compensation expense, value		661,005			661,005
Share based compensation expense, shares
Issuance of stock for cash, net of issuance costs, value	$ 2,028	4,447,972			4,450,000
Issuance of stock for cash, net of issuance costs, shares	20,277,778
Contributions from non-controlling interest				6,714,856	6,714,856
Stock issued to settle royalty agreement, value	$ 10	35,990			36,000
Stock issued to settle royalty agreement, shares	100,000
Compensation Warrants		592,638			592,638
Inducement dividend from warrant exercises		2,861,436	(2,861,436)
Cumulative effect of the new lease standard					0
Net Loss			(14,906,989)	(475,559)	(15,382,548)
Stockholders Equity, Ending balance at Sep. 30, 2018	$ 22,176	88,860,249	(75,997,660)	9,122,287	22,007,052
Shares, Outstanding, Ending Balance at Sep. 30, 2018	221,760,237
Stockholders Equity, Beginning balance at Jun. 30, 2018	$ 18,605	79,540,062	(66,169,341)	6,498,846	19,888,172
Shares, Outstanding Beginning balance at Jun. 30, 2018	186,051,491
Issuance of stock for debt conversion, value	$ 1,318	3,294,703			3,296,021
Issuance of stock for debt conversion, shares	13,184,087
Exercise of warrants for stock, value	$ 166	424,886			425,052
Exercise of warrants for stock, shares	1,656,125
Share based compensation expense, value	$ 49	435,328			435,377
Share based compensation expense, shares	490,756
Issuance of stock for cash, net of issuance costs, value	$ 2,028	4,447,972			4,450,000
Issuance of stock for cash, net of issuance costs, shares	20,277,778
Contributions from non-controlling interest				2,914,857	2,914,857
Stock issued to settle royalty agreement, value	$ 10	35,990			36,000
Stock issued to settle royalty agreement, shares	100,000
Compensation Warrants		592,638			592,638
Inducement dividend from warrant exercises		88,670	(88,670)
Net Loss			(9,739,649)	(291,416)	(10,031,065)
Stockholders Equity, Ending balance at Sep. 30, 2018	$ 22,176	88,860,249	(75,997,660)	9,122,287	22,007,052
Shares, Outstanding, Ending Balance at Sep. 30, 2018	221,760,237
Stockholders Equity, Beginning balance at Mar. 31, 2019	$ 24,063	93,020,015	(84,743,836)	8,855,757	17,155,999
Shares, Outstanding Beginning balance at Mar. 31, 2019	240,627,102
Issuance of stock for debt conversion, value	$ 200	279,800			280,000
Issuance of stock for debt conversion, shares	2,000,000
Exercise of warrants for stock, value	$ 945	849,533			850,478
Exercise of warrants for stock, shares	9,449,750
Share based compensation expense, value		208,809			208,809
Share based compensation expense, shares
Issuance of stock for cash, net of issuance costs, value	$ 367	478,329			478,696
Issuance of stock for cash, net of issuance costs, shares	3,668,167
Beneficial conversion feature on notes payable		133,806			133,806
Contributions from non-controlling interest				550,001	550,001
Compensation Warrants		132,914			132,914
Cancellation of shares issued to consultant, value	$ (40)	40
Cancellation of shares issued to consultant, shares	(400,000)
Inducement dividend from warrant exercises		230,025	(230,025)
Cumulative effect of the new lease standard			(7,550)		(7,550)
Net Loss			(5,089,709)	(377,781)	(5,467,490)
Stockholders Equity, Ending balance at Sep. 30, 2019	$ 25,535	95,333,271	(90,071,120)	9,027,977	14,315,663
Shares, Outstanding, Ending Balance at Sep. 30, 2019	255,345,019
Stockholders Equity, Beginning balance at Jun. 30, 2019	$ 24,686	94,095,065	(87,232,454)	8,723,541	15,610,838
Shares, Outstanding Beginning balance at Jun. 30, 2019	246,852,769
Issuance of stock for debt conversion, value	$ 100	109,900			110,000
Issuance of stock for debt conversion, shares	1,000,000
Exercise of warrants for stock, value	$ 749	673,553			674,302
Exercise of warrants for stock, shares	7,492,250
Share based compensation expense, value		32,408			32,408
Share based compensation expense, shares
Beneficial conversion feature on notes payable		133,806			133,806
Contributions from non-controlling interest				550,001	550,001
Compensation Warrants		132,914			132,914
Inducement dividend from warrant exercises		155,625	(155,625)
Net Loss			(2,683,041)	(245,565)	(2,928,606)
Stockholders Equity, Ending balance at Sep. 30, 2019	$ 25,535	$ 95,333,271	$ (90,071,120)	$ 9,027,977	$ 14,315,663
Shares, Outstanding, Ending Balance at Sep. 30, 2019	255,345,019